Wavely Diagnostics, Inc.
Wavely Diagnostics, Inc. is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Wavely Diagnostics, Inc..
Wavely Diagnostics, Inc. is a company.
Key people at Wavely Diagnostics, Inc..
Key people at Wavely Diagnostics, Inc..
Wavely Diagnostics, Inc. develops smartphone-based diagnostic apps that transform everyday phones into tools for remote pediatric exams, starting with ear infections. The company serves parents and healthcare providers by solving the problem of inaccessible in-person care for common childhood issues like acute otitis media (AOM), enabling virtual diagnoses via acoustic reflectometry and machine learning without extra hardware.[1][2][3][5] Its Ear Infection Bundle pairs an app detecting middle ear fluid—using a disposable or DIY paper funnel—with integrated telehealth for provider evaluation and prescriptions, reducing urgent care visits.[1][3] With $6.35MM in total funding (including $1.35MM recently and NIH grants), Wavely shows strong growth momentum through pilots with U.S. health systems and preparations for wide commercialization.[3][4][5]
Formerly Edus Health, founded in 2018 in Seattle, the company is woman-owned and positions itself to shift nearly 70% of acute pediatric visits to virtual care.[1][3][5]
Wavely Diagnostics spun out from the University of Washington and Seattle Children’s Hospital, leveraging academic research in acoustic reflectometry for ear diagnostics.[2][5] The idea emerged from NIH-funded projects, including a 2019 Phase I SBIR grant ($223,857) to optimize algorithms and funnels for lay users, followed by a Direct to Phase II grant ($1.79MM) for calibration, clinical validation, and telehealth API integration.[5] Early traction came via prototypes tested in physician and parent groups, evolving into pilots like a successful Phase I and ongoing Phase II with a major U.S. health system.[3]
Leadership drives this: CEO Arna Ionescu Stoll (20+ years in design thinking and digital health), Chief Health Officer Jacob Reider (family medicine expert in ear infections), CFO Ehud Gelblum (unicorn exit experience), and advisors like Dmitry Kaplan (30+ years in signal processing/ML) and pediatric specialists from Seattle Children’s.[2]
Wavely rides the telehealth boom post-COVID, where virtual pediatric care demand surged but lacked reliable remote physical exams—especially for kids, who drive 30%+ of visits for ear issues.[1][3] Timing aligns with payer/provider push for scalable virtual solutions amid clinician shortages and rural access gaps; its smartphone-only model lowers costs vs. hardware rivals like TytoCare.[1][3] Market forces favor it: $6.35MM funding reflects investor bet on digital diagnostics amid rising acute care costs, while NIH grants target disparities.[3][5] Wavely influences the ecosystem by pioneering lay-user tools, potentially standardizing acoustic screening in global telehealth and enabling 70% virtual pediatric shifts.[2][3]
Wavely is primed for commercial launch post-Phase II pilots, with new $1.35MM funding fueling partnerships and scaling—watch for payer integrations and expansion to respiratory/strep diagnostics.[3] Trends like AI-driven remote monitoring and value-based care will accelerate adoption, especially in underserved areas. Its influence could evolve from ear infections niche to platform leader, redefining pediatric telehealth accessibility and cutting ER reliance, building on its university roots to deliver high-impact, equitable care.
